These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8838446)

  • 21. Adverse reactions to radiopharmaceuticals in France: analysis of the national pharmacovigilance database.
    Laroche ML; Quelven I; Mazère J; Merle L
    Ann Pharmacother; 2015 Jan; 49(1):39-47. PubMed ID: 25366341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of age, sex and seriousness on reporting of adverse drug reactions in Sweden.
    Holm L; Ekman E; Jorsäter Blomgren K
    Pharmacoepidemiol Drug Saf; 2017 Mar; 26(3):335-343. PubMed ID: 28071845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropsychiatric reactions to drugs: an analysis of spontaneous reports from general practitioners in Italy.
    Galatti L; Giustini SE; Sessa A; Polimeni G; Salvo F; Spina E; Caputi AP
    Pharmacol Res; 2005 Mar; 51(3):211-6. PubMed ID: 15661570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse drug reaction reporting: how can drug consumption information add to analyses using spontaneous reports?
    Svendsen K; Halvorsen KH; Vorren S; Samdal H; Garcia B
    Eur J Clin Pharmacol; 2018 Apr; 74(4):497-504. PubMed ID: 29255992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Incidence and prevalence of adverse drug reactions].
    Haramburu F; Pouyanne P; Imbs JL; Blayac JP; Bégaud B
    Presse Med; 2000 Jan; 29(2):111-4. PubMed ID: 10682042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden.
    Ekman E; Bäckström M
    Eur J Clin Pharmacol; 2009 Jan; 65(1):43-6. PubMed ID: 18825377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. French pharmacovigilance: Missions, organization and perspectives.
    Vial T
    Therapie; 2016 Apr; 71(2):143-50. PubMed ID: 27080832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse drug reactions of analgesic medicines: analysis of the Romanian pharmacovigilance database.
    Cazacu I; Stroe R; Dondera R; Mogosan C; Haramburu F; Fourrier-Réglat A; Loghin F
    Fundam Clin Pharmacol; 2018 Jun; 32(3):330-336. PubMed ID: 29314262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse Drug Reactions Reported With Cholinesterase Inhibitors: An Analysis of 16 Years of Individual Case Safety Reports From VigiBase.
    Kröger E; Mouls M; Wilchesky M; Berkers M; Carmichael PH; van Marum R; Souverein P; Egberts T; Laroche ML
    Ann Pharmacother; 2015 Nov; 49(11):1197-206. PubMed ID: 26324356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse drug reactions of non-opioid and opioid analgesics reported to Croatian national authority from 2007 to 2014.
    Sunara P; Krnic D; Puljak L
    Acta Med Acad; 2017 Nov; 46(2):94-104. PubMed ID: 29338273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The quality of spontaneous adverse drug reaction reports from the pharmacovigilance centre in western China.
    Niu R; Xiang Y; Wu T; Zhang Z; Chen Y; Feng B
    Expert Opin Drug Saf; 2019 Jan; 18(1):51-58. PubMed ID: 30574811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses' reporting.
    Karlsson SA; Jacobsson I; Boman MD; Hakkarainen KM; Lövborg H; Hägg S; Jönsson AK
    Eur J Clin Pharmacol; 2015 May; 71(5):631-6. PubMed ID: 25845655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feedback for patients reporting adverse drug reactions; satisfaction and expectations.
    Rolfes L; van Hunsel F; van Grootheest K; van Puijenbroek E
    Expert Opin Drug Saf; 2015 May; 14(5):625-32. PubMed ID: 25766456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse drug reactions at adverse drug reaction monitoring center in Raipur: Analysis of spontaneous reports during 1 year.
    Singh P; Agrawal M; Hishikar R; Joshi U; Maheshwari B; Halwai A
    Indian J Pharmacol; 2017; 49(6):432-437. PubMed ID: 29674797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse drug reactions in a psychiatric department of tertiary care teaching hospital in India: Analysis of spontaneously reported cases.
    Patel TK; Bhabhor PH; Desai N; Shah S; Patel PB; Vatsala E; Panigrahi S
    Asian J Psychiatr; 2015 Oct; 17():42-9. PubMed ID: 26216702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse Drug Reaction (ADR) Monitoring at the Eastern Regional Pharmacovigilance Centre, Nepal.
    Rauniar GP; Panday DR
    Kathmandu Univ Med J (KUMJ); 2017 Oct.-Dec.; 15(60):296-300. PubMed ID: 30580345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reporting of adverse drug reactions by hospital doctors and the response to intervention.
    McGettigan P; Golden J; Conroy RM; Arthur N; Feely J
    Br J Clin Pharmacol; 1997 Jul; 44(1):98-100. PubMed ID: 9241104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse drug reactions in children: a ten-year review of reporting to the Portuguese Pharmacovigilance System.
    Nogueira Guerra L; Herdeiro MT; Ribeiro-Vaz I; Clérigo MI; Rocha C; Araújo A; Pêgo A; Rebelo Gomes E
    Expert Opin Drug Saf; 2015; 14(12):1805-13. PubMed ID: 26549822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse drug reactions in Colombian patients, 2007-2013: Analysis of population databases.
    Machado-Alba JE; Londoño-Builes MJ; Echeverri-Cataño LF; Ochoa-Orozco SA
    Biomedica; 2016 Mar; 36(1):59-66. PubMed ID: 27622439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Filling quality of the reports of adverse drug reactions received at the Pharmacovigilance Centre of São Paulo (Brazil): missing information hinders the analysis of suspected associations.
    Ribeiro A; Lima S; Zampieri ME; Peinado M; Figueras A
    Expert Opin Drug Saf; 2017 Dec; 16(12):1329-1334. PubMed ID: 28817316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.